[Pathogenetic mechanisms of platelet hyperaggregation in diabetics (author's transl)].
D000818:Animals; D001095:Arachidonic Acids / Q000494:pharmacology*; D001792:Blood Platelets / Q000378:metabolism; D003402:Creatine Kinase / Q000378:metabolism; D003920:Diabetes Mellitus / Q000097:blood* / Q000378:metabolism; D003930:Diabetic Retinopathy / Q000097:blood / Q000378:metabolism; D011464:Epoprostenol / Q000494:pharmacology; D000431:Ethanol / Q000494:pharmacology; D006801:Humans; D007093:Imidazoles / Q000494:pharmacology; D010725:Phosphocreatine / Q000378:metabolism; D010974:Platelet Aggregation / Q000187:drug effects*; D051381:Rats
D001095:Arachidonic Acids; D007093:Imidazoles; D010725:Phosphocreatine; D000431:Ethanol; C029899:imidazole; D011464:Epoprostenol; D003402:Creatine Kinase
Mecanismos patogénicos de la hiperagregación plaquetaria en los diabéticos.